Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. (Q39883131)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Pavel Sluka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Rod Dunbar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Denis Corbeil

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jonathan Cebon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

Craig Gedye

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Juliet Quirk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Judy Browning

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Suzanne Svobodová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ian D Davis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

17 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1635-1646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-009-0672-0

21 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0672-0

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00262-009-0672-0

10.1007/S00262-009-0672-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19221743%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference